Zum Inhalt springen
Black Friday — 30% OFFKostenloser Versand ab 99 € Bestellwert
  1. Startseite
  2. Hormonelle Gesundheit und Wachstum
  3. GHRP-2 5mg
Hormonelle Gesundheit

GHRP-2 5mg

GHRP-2 (Pralmorelin) is a synthetic hexapeptide compound studied for selective ghrelin receptor binding properties and growth hormone secretagogue signalling in experimental models.

Darreichungsform: GHRP-2 5mg.

Gewünschte Stärke und Packungsgröße auswählen.

Mit KI erstellte illustrative Verpackung.

Darreichungsform
Ursprünglicher Preis war: 199,50 €Aktueller Preis ist: 139,65 €.

Auf Anfrage erhältlich in Deutschland

Berater fragen
Ein Berater meldet sich bei Ihnen, und die Partnerapotheke prüft, ob und wie es weitergehen kann. Ein gültiges Rezept oder eine Beurteilung durch einen zugelassenen Telemedizin-Dienst kann erforderlich sein.
  • Partnerapotheke
  • Persönliche Betreuung
  • Diskrete Lieferung
  • Darreichungsform
    GHRP-2 5mg

Versand und Lieferung

  • Versand in der Regel innerhalb von 24 Stunden nach Zahlungsbestätigung.
  • USPS Regular Shipping · 11,95 € · Ca. 3–5 Werktage
  • FedEx 2 Days Delivery · 28,99 € · Ca. 2 Werktage
  • FedEx Overnight Delivery · 40,99 € · Ca. 1 Werktag

Nur für die Laborforschung.

Nicht zur Anwendung bei Menschen oder Tieren.

Zusammensetzung und Produktdetails

Übersicht

GHRP-2 (Pralmorelin) is a synthetic hexapeptide compound studied for selective ghrelin receptor binding properties and growth hormone secretagogue signalling in experimental models.

The compound consists of six amino acids (D-Ala-D-β-Nal-Ala-Trp-D-Phe-Lys-NH2) and is examined for its capacity to engage the GHS-R1a (growth hormone secretagogue receptor 1a) in pituitary and hypothalamic research models. Research applications include ghrelin receptor pharmacology, growth hormone secretagogue pathway studies, and pulsatile GH signalling research.

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only

Eigenschaften

Chemical Formula C45H55N9O6
Synonyms Pralmorelin, KP-102, D-Alanyl-3-(2-naphthalenyl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide, UNII-E6S6E1F19M
Molar Mass 817.9865 g/mol
CAS Number 158861-67-7
PubChem CID 6918245
Verfügbare Formate GHRP-2 5mg (1 vial) · GHRP-2 5mg KIT (10 vials)
Shelf Life 36 months

Forschung

GHRP-2 (Pralmorelin) is a synthetic hexapeptide studied as a potent agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R1a) in laboratory research models. The compound’s six-amino-acid sequence (D-Ala-D-β-Nal-Ala-Trp-D-Phe-Lys-NH2) is studied for selective receptor binding at GHS-R1a sites located in pituitary somatotroph cells and hypothalamic nuclei, with downstream research interest in pulsatile growth hormone secretagogue signalling and IGF-1 axis modulation. Research models have also examined GHRP-2’s proposed somatostatin suppression activity — studied as a mechanism through which it may amplify growth hormone release beyond direct receptor agonism — and its capacity to modulate cAMP production, calcium mobilization, and PKA/PKC signalling cascades in pituitary cell models. Independently third-party HPLC-tested; COA available per batch.

FAQ

What receptor does GHRP-2 bind to and how is this studied in laboratory models?

GHRP-2 is studied for selective agonist activity at the GHS-R1a (growth hormone secretagogue receptor 1a), which is expressed in pituitary somatotroph cells and hypothalamic nuclei. Cell-based binding assays using GHS-R1a-expressing cell lines, alongside downstream signalling readouts (such as cAMP accumulation and calcium mobilization), are standard methods for characterising GHRP-2’s receptor engagement and functional potency relative to other GHS-R1a ligands.

What distinguishes GHRP-2’s proposed mechanism from GHRH-based research tools?

GHRP-2 engages the ghrelin/GHS-R1a receptor pathway, distinct from the GHRH receptor pathway targeted by GHRH analogues such as CJC-1295. Research protocols frequently pair GHRP-2 with GHRH analogues to examine whether GHS-R1a agonism and GHRH receptor activation produce synergistic effects on growth hormone secretagogue signalling endpoints, a common combination design in pituitary pathway research.

What experimental controls are commonly used in GHRP-2 receptor-signalling research?

Studies investigating GHRP-2 mechanisms typically incorporate vehicle controls, receptor-antagonist controls, and comparator GHS-R1a agonists to distinguish receptor-specific effects from non-specific pathway activation.

Comparative experiments using compounds such as GHRP-6 or Ipamorelin are commonly employed to evaluate differences in signalling selectivity, pathway activation patterns, receptor responsiveness, and downstream transcriptional responses. These approaches help establish mechanistic attribution in GHS-R1a pharmacology research.

Ursprünglicher Preis war: 199,50 €Aktueller Preis ist: 139,65 €.